{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:29:48Z","timestamp":1791318588531,"version":"4.3.1"},"reference-count":61,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Molecular Biology"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.jmb.2009.02.007","type":"journal-article","created":{"date-parts":[[2009,2,18]],"date-time":"2009-02-18T00:11:55Z","timestamp":1234915915000},"page":"771-785","source":"Crossref","is-referenced-by-count":90,"title":["Dopamine and the Dopamine Oxidation Product 5,6-Dihydroxylindole Promote Distinct On-Pathway and Off-Pathway Aggregation of \u03b1-Synuclein in a pH-Dependent Manner"],"prefix":"10.1016","volume":"387","author":[{"given":"Chi L.L.","family":"Pham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Ling","family":"Leong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feda E.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijaya B.","family":"Kenche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew F.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally L.","family":"Gras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Barnham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Cappai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmb.2009.02.007_bib1","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2009.02.007_bib2","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","article-title":"Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies","volume":"95","author":"Spillantini","year":"1998","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.jmb.2009.02.007_bib3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","article-title":"Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease","volume":"18","author":"Kruger","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jmb.2009.02.007_bib4","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.jmb.2009.02.007_bib5","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"Alpha-synuclein locus triplication causes Parkinson's disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jmb.2009.02.007_bib6","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ana.10795","article-title":"The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia","volume":"55","author":"Zarranz","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jmb.2009.02.007_bib7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00401-006-0096-2","article-title":"Interaction of alpha-synuclein and dopamine metabolites in the pathogenesis of Parkinson's disease: a case for the selective vulnerability of the substantia nigra","volume":"112","author":"Galvin","year":"2006","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jmb.2009.02.007_bib8","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1006\/jmbi.2001.4538","article-title":"Conformational properties of alpha-synuclein in its free and lipid-associated states","volume":"307","author":"Eliezer","year":"2001","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2009.02.007_bib9","doi-asserted-by":"crossref","first-page":"9443","DOI":"10.1074\/jbc.273.16.9443","article-title":"Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes","volume":"273","author":"Davidson","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2009.02.007_bib10","doi-asserted-by":"crossref","first-page":"15313","DOI":"10.1074\/jbc.M213128200","article-title":"A broken alpha-helix in folded alpha-synuclein","volume":"278","author":"Chandra","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2009.02.007_bib11","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0896-6273(95)90302-X","article-title":"The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system","volume":"14","author":"Iwai","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.jmb.2009.02.007_bib12","doi-asserted-by":"crossref","first-page":"11282","DOI":"10.1073\/pnas.90.23.11282","article-title":"Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease","volume":"90","author":"Ueda","year":"1993","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.jmb.2009.02.007_bib13","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1074\/jbc.M008919200","article-title":"A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly","volume":"276","author":"Giasson","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2009.02.007_bib14","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nrn983","article-title":"Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein","volume":"3","author":"Lotharius","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jmb.2009.02.007_bib15","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1523\/JNEUROSCI.22-08-03090.2002","article-title":"A role for alpha-synuclein in the regulation of dopamine biosynthesis","volume":"22","author":"Perez","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jmb.2009.02.007_bib16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0896-6273(00)80886-7","article-title":"Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system","volume":"25","author":"Abeliovich","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.jmb.2009.02.007_bib17","doi-asserted-by":"crossref","first-page":"11869","DOI":"10.1073\/pnas.97.22.11869","article-title":"Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles","volume":"97","author":"Sulzer","year":"2000","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.jmb.2009.02.007_bib18","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S0026-895X(25)13536-0","article-title":"Autooxidation versus covalent binding of quiones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds towards C1300 neuroblastoma cells in vitro","volume":"14","author":"Graham","year":"1978","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jmb.2009.02.007_bib19","doi-asserted-by":"crossref","first-page":"15597","DOI":"10.1074\/jbc.M610893200","article-title":"Kinetic and structural analysis of the early oxidation products of dopamine: analysis of the interactions with alpha-synuclein","volume":"282","author":"Bisaglia","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2009.02.007_bib20","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1021\/bi991447r","article-title":"Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid","volume":"39","author":"Conway","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmb.2009.02.007_bib21","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/3311","article-title":"Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease","volume":"4","author":"Conway","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.jmb.2009.02.007_bib22","doi-asserted-by":"crossref","first-page":"7619","DOI":"10.1074\/jbc.274.12.7619","article-title":"Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro","volume":"274","author":"Giasson","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2009.02.007_bib23","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1073\/pnas.97.2.571","article-title":"Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy","volume":"97","author":"Conway","year":"2000","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.jmb.2009.02.007_bib24","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/418291a","article-title":"Neurodegenerative disease: amyloid pores from pathogenic mutations","volume":"418","author":"Lashuel","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2009.02.007_bib25","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0022-2836(02)00735-0","article-title":"Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils","volume":"322","author":"Lashuel","year":"2002","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2009.02.007_bib26","doi-asserted-by":"crossref","first-page":"10209","DOI":"10.1021\/bi020139h","article-title":"Annular alpha-synuclein protofibrils are produced when spherical protofibrils are incubated in solution or bound to brain-derived membranes","volume":"41","author":"Ding","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmb.2009.02.007_bib27","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1021\/bi701522m","article-title":"Formation of a high affinity lipid-binding intermediate during the early aggregation phase of alpha-synuclein","volume":"47","author":"Smith","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmb.2009.02.007_bib28","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1096\/fj.04-3437fje","article-title":"Dopamine promotes alpha-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathway","volume":"19","author":"Cappai","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.jmb.2009.02.007_bib29","doi-asserted-by":"crossref","first-page":"21212","DOI":"10.1074\/jbc.M412621200","article-title":"Reversible inhibition of alpha-synuclein fibrillization by dopaminochrome-mediated conformational alterations","volume":"280","author":"Norris","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2009.02.007_bib30","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1126\/science.1063522","article-title":"Kinetic stabilization of the alpha-synuclein protofibril by a dopamine\u2013alpha-synuclein adduct","volume":"294","author":"Conway","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.jmb.2009.02.007_bib31","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1096\/fj.03-0770fje","article-title":"Dopamine and l-DOPA disaggregate amyloid fibrils: implications for Parkinson's and Alzheimer's disease","volume":"18","author":"Li","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.jmb.2009.02.007_bib32","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0022-2836(02)00775-1","article-title":"Dependence of alpha-synuclein aggregate morphology on solution conditions","volume":"322","author":"Hoyer","year":"2002","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2009.02.007_bib33","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0026-895X(25)13535-9","article-title":"Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones","volume":"14","author":"Graham","year":"1978","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jmb.2009.02.007_bib34","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S0026-895X(25)13536-0","article-title":"Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro","volume":"14","author":"Graham","year":"1978","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jmb.2009.02.007_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.freeradbiomed.2009.02.009","article-title":"Formation of dopamine-mediated \u03b1-synuclein soluble oligomers requires methionine oxidation","author":"Leong","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.jmb.2009.02.007_bib36","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbapap.2004.10.008","article-title":"Methionine oxidation, alpha-synuclein and Parkinson's disease","volume":"1703","author":"Glaser","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jmb.2009.02.007_bib37","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1017\/S0033583502003815","article-title":"What vibrations tell us about proteins","volume":"35","author":"Barth","year":"2002","journal-title":"Q. Rev. Biophys."},{"key":"10.1016\/j.jmb.2009.02.007_bib38","doi-asserted-by":"crossref","first-page":"10737","DOI":"10.1074\/jbc.M010907200","article-title":"Evidence for a partially folded intermediate in \u03b1-synuclein fibril formation","volume":"276","author":"Uversky","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2009.02.007_bib39","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0005-2728(02)00365-1","article-title":"Mitochondrial damage by nitric oxide is potentiated by dopamine in PC12 cell","volume":"1556","author":"Antunes","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jmb.2009.02.007_bib40","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3109\/10715769609088005","article-title":"Evaluation of the pro-oxidant and antioxidant actions of l-DOPA and dopamine in vitro: implications for Parkinson's disease","volume":"24","author":"Spencer","year":"1996","journal-title":"Free Radical Res."},{"key":"10.1016\/j.jmb.2009.02.007_bib41","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1021\/bi061871+","article-title":"Dopamine affects the stability, hydration, and packing of protofibrils and fibrils of the wild type and variants of alpha-synuclein","volume":"46","author":"Follmer","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmb.2009.02.007_bib42","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/334345a0","article-title":"Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease","volume":"334","author":"Hirsch","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2009.02.007_bib43","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.tins.2003.08.009","article-title":"Neuromelanin of the substantia nigra: a neuronal black hole with protective and toxic characteristics","volume":"26","author":"Zecca","year":"2003","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.jmb.2009.02.007_bib44","doi-asserted-by":"crossref","first-page":"19509","DOI":"10.1074\/jbc.274.28.19509","article-title":"Alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease","volume":"274","author":"Wood","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2009.02.007_bib45","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1006\/jsbi.2000.4268","article-title":"Amyloid fibril formation from full-length and fragments of amylin","volume":"130","author":"Goldsbury","year":"2000","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.jmb.2009.02.007_bib46","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jsb.2004.08.002","article-title":"The binding of thioflavin-T to amyloid fibrils: localisation and implications","volume":"149","author":"Krebs","year":"2005","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.jmb.2009.02.007_bib47","doi-asserted-by":"crossref","first-page":"6601","DOI":"10.1016\/j.febslet.2005.10.048","article-title":"Chiral bias of amyloid fibrils revealed by the twisted conformation of thioflavin T: an induced circular dichroism\/DFT study","volume":"579","author":"Dzwolak","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jmb.2009.02.007_bib48","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jmb.2003.10.044","article-title":"Solid state NMR reveals a pH-dependent antiparallel beta-sheet registry in fibrils formed by a beta-amyloid peptide","volume":"335","author":"Petkova","year":"2004","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2009.02.007_bib49","doi-asserted-by":"crossref","first-page":"16742","DOI":"10.1073\/pnas.262663499","article-title":"A structural model for Alzheimer's beta-amyloid fibrils based on experimental constraints from solid state NMR","volume":"99","author":"Petkova","year":"2002","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.jmb.2009.02.007_bib50","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1126\/science.1105850","article-title":"Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils","volume":"307","author":"Petkova","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.jmb.2009.02.007_bib51","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/416507a","article-title":"Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases","volume":"416","author":"Bucciantini","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2009.02.007_bib52","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","article-title":"Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis","volume":"300","author":"Kayed","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jmb.2009.02.007_bib53","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","article-title":"Diffusible, nonfibrillar ligands derived from Abeta1\u201342 are potent central nervous system neurotoxins","volume":"95","author":"Lambert","year":"1998","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.jmb.2009.02.007_bib54","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.neuro.26.010302.081142","article-title":"Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders","volume":"26","author":"Caughey","year":"2003","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.jmb.2009.02.007_bib55","doi-asserted-by":"crossref","first-page":"7812","DOI":"10.1021\/bi0102398","article-title":"Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinson's disease","volume":"40","author":"Volles","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmb.2009.02.007_bib56","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1021\/bi0121353","article-title":"Vesicle permeabilization by protofibrillar alpha-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism","volume":"41","author":"Volles","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmb.2009.02.007_bib57","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/j.1460-9568.2006.04610.x","article-title":"H MRS identifies lactate rise in the striatum of MPTP-treated C57BL\/6 mice","volume":"23","author":"Koga","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.jmb.2009.02.007_bib58","first-page":"61","article-title":"Proton MR spectroscopy of the brain in 14 patients with Parkinson disease","volume":"16","author":"Bowen","year":"1995","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.jmb.2009.02.007_bib59","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ymeth.2004.03.012","article-title":"Techniques to study amyloid fibril formation in vitro","volume":"34","author":"Nilsson","year":"2004","journal-title":"Methods"},{"key":"10.1016\/j.jmb.2009.02.007_bib60","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1006\/jmbi.1997.1348","article-title":"Common core structure of amyloid fibrils by synchrotron X-ray diffraction","volume":"273","author":"Sunde","year":"1997","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2009.02.007_bib61","doi-asserted-by":"crossref","first-page":"11738","DOI":"10.1021\/ja063751v","article-title":"X-ray scattering study of the effect of hydration on the cross-beta structure of amyloid fibrils","volume":"128","author":"Squires","year":"2006","journal-title":"J. Am. Chem. Soc."}],"container-title":["Journal of Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283609001491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283609001491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T19:46:43Z","timestamp":1738957603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022283609001491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0022283609001491"],"URL":"https:\/\/doi.org\/10.1016\/j.jmb.2009.02.007","relation":{},"ISSN":["0022-2836"],"issn-type":[{"value":"0022-2836","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}